[1] 向凤玲, 王远坤, 王小燕, 等. 中国儿童青少年高尿酸血症患病率的Meta分析[J].中国全科医学, 2025, 28(33): 4206-4213.
Xiang FL, Wang YK, Wang XY, et al. The prevalence of hyperuricemia among children and adolescents in China: A meta-analysis[J]. Chin Gen Pract, 2025, 28(33): 4206-4213. (in Chinese)
[2] Faienza MF, Cognetti E, Farella I, et al. Dietary fructose: From uric acid to a metabolic switch in pediatric metabolic dysfunction-associated steatotic liver disease[J]. Crit Rev Food Sci Nutr, 2025, 65(23): 4583-4598.
[3] 朱博文, 王同帅, 王星云, 等.血尿酸水平对儿童青少年代谢综合征及其组分的影响[J].中国儿童保健杂志, 2025, 33(5): 489-496.
Zhu BW, Wang TS, Wang XY, et al. Effect of serum uric acid levels on metabolic syndrome and its components in children and adolescents[J]. Chin J Child Health Care, 2025, 33(5): 489-496. (in Chinese)
[4] Zhang J, Sun N, Zhang W, et al. The impact of uric acid on musculoskeletal diseases: Clinical associations and underlying mechanisms[J]. Front Endocrinol, 2025, 16: 1515176.
[5] Moulin-Mares SRA, Oliosa PR, Faria ER, et al. Association of uric acid with cardiovascular risk in Brazilian children and adolescents[J]. Nutr Metab Cardiovasc Dis, 2021, 31(1): 314-321.
[6] Stiburkova B, Lukesova M, Zeman J. Pediatrics hyperuricemia in clinical practice: A retrospective analysis in 1 753 children and adolescents with hyperuricemia[J]. Jt Bone Spine, 2025, 92(1): 105796.
[7] You SY, Cho SI, Suh JS. Clinical and dietary risk factors of hyperuricemia in Korean children and adolescents: The 8th Korea National Health and Nutrition Examination Survey[J]. Kidney Res Clin Pract, 2025, 44(6): 950-959.
[8] Kitoh T, Yamana T, Imura H, et al. Age and gender-specific reference intervals for uric acid level and hyperuricemia in children with Down syndrome[J]. Pediatr Int, 2025, 67(1): e15863.
[9] 高雨霏,张力之,朱文萱,等.中国儿童青少年代谢综合征患病率的Meta分析[J].数理医药学杂志, 2024, 37(12): 922-934.
Gao YF, Zhang LZ, Zhu WX, et al. Prevalence of metabolic syndrome in Chinese children and adolescents: A Meta-analysis[J]. J Math Med, 2024, 37(12): 922-934. (in Chinese)
[10] 叶佩玉,赵小元,闫银坤,等.儿童高尿酸血症与心血管代谢异常发生风险[J].中华流行病学杂志, 2021, 42(3): 433-439.
Ye PY, Zhao XY, Yan YK, et al. Association between hyperuricemia and incidence risk for cardiometabolic abnormity in children[J]. Chin J Epidemiol, 2021, 42(3): 433-439. (in Chinese)
[11] Xie L, Mo PKH, Tang Q, et al. Skeletal muscle mass has stronger association with the risk of hyperuricemia than body fat mass in obese children and adolescents[J]. Front Nutr, 2022, 9: 792234.
[12] Reis LN, Borfe L, Brand C, et al. Food consumption is associated with hyperuricemia in boys[J]. High Blood Press Cardiovasc Prev, 2020, 27(5): 409-415.
[13] Kim HJ. Association between hyperuricemia and dehydration in children with acute gastroenteritis[J]. Pediatr Emerg Care, 2026, 42(2): 91-95.
[14] Taner S, Gezici E, Unal A, et al. The association of obesity and hyperuricemia with ambulatory blood pressure in children[J]. Pediatr Nephrol, 2025, 40(3): 787-796.
[15] Elitok GK, Duru NS, Elevli M, et al. Prevalence of metabolic syndrome in middle school children and evaluation of components of metabolic syndrome[J]. Sisli Etfal Hastan Tip Bul, 2019, 53(4): 403-408.
[16] Cassano V, Crescibene D, Hribal ML, et al. Uric acid and vascular damage in essential hypertension: Role of insulin resistance[J]. Nutrients, 2020, 12(9): 2509.
[17] Zhang Y, Zhang H, Rong S, et al. NMR spectroscopy based metabolomics confirms the aggravation of metabolic disorder in metabolic syndrome combined with hyperuricemia[J]. Nutr Metab Cardiovasc Dis, 2021, 31(8): 2449-2457.
[18] Yu W, Xie D, Yamamoto T, et al. Mechanistic insights of soluble uric acid-induced insulin resistance: Insulin signaling and beyond[J]. Rev Endocr Metab Disord, 2023, 24(2): 327-343.
[19] Timsans J, Kauppi J, Rantalaiho V, et al. Serum uric acid is associated with insulin resistance in non-diabetic subjects[J]. J Clin Med, 2025, 14(8): 2621.
[20] Vareldzis R, Perez A, Reisin E. Hyperuricemia: An intriguing connection to metabolic syndrome, diabetes, kidney disease, and hypertension[J]. Curr Hypertens Rep, 2024, 26(6): 237-245.
[21] González-Domínguez Á, Belmonte T, Domínguez-Riscart J, et al. Altered insulin secretion dynamics relate to oxidative stress and inflammasome activation in children with obesity and insulin resistance[J]. J Transl Med, 2023, 21(1): 559.
[22] Kim YJ, Kim S, Seo JH, et al. Prevalence and associations between metabolic syndrome components and hyperuricemia by race: Findings from US population, 2011-2020[J]. Arthritis Care Res, 2024, 76(8): 1195-1202.
[23] Zhang X, Liu J. Regulating lipid metabolism in gout: A new perspective with therapeutic potential[J]. Int J Gen Med, 2024, 17: 5203-5217.
[24] Liu N, Sun Q, Xu H, et al. Hyperuricemia induces lipid disturbances mediated by LPCAT3 upregulation in the liver[J]. FASEB J, 2020, 34(10): 13474-13493.
[25] Liu Y, Li Z, Xu Y, et al. Uric acid and atherosclerosis in patients with chronic kidney disease: Recent progress, mechanisms, and prospect[J]. Kidney Dis (Basel), 2025, 11(1): 112-127.
[26] Yu J, Liu X, Ji H, et al. Distribution of serum uric acid concentration and its association with lipid profiles: A single-center retrospective study in children aged 3 to 12 years with adenoid and tonsillar hypertrophy[J]. Lipids Health Dis, 2023, 22(1): 48.
[27] Chiang YF, Huang KC, Huang YJ, et al. Hinokitiol modulates Nrf2/HO-1 signaling, autophagy, and URAT1 in hyperuricemia and oxidative stress models of renal injury[J]. Free Radic Biol Med, 2025, 238: 169-178.
[28] Banik SD, Avila-Nava A, Lugo R, et al. Association between low-grade inflammation and hyperuricemia in adults with metabolic syndrome in Yucatán, México[J]. Can J Diabetes, 2022, 46(4): 369-374.
[29] Qian Y, Zhang Y, Chen Y, et al. Linarin attenuates hyperuricemic nephropathy by modulating Nrf2/Keap1 and TLR4/NF-κB signaling pathways: Linarin attenuates hyperuricemic nephropathy[J]. Phytomedicine, 2025,139:156440.
[30] Koutsaliaris IK, Moschonas IC, Pechlivani LM, et al. Inflammation, oxidative stress, vascular aging and atherosclerotic ischemic stroke[J].Curr Med Chem, 2022, 29(34): 5496-5509.
[31] Masi S, Georgiopoulos G, Alexopoulos G, et al. The complex relationship between serum uric acid, endothelial function and small vessel remodeling in humans[J]. J Clin Med, 2020, 9(7): 2027.
[32] Zhang J, Lei W, Zhou J, et al. Uric acid promotes aortic valve calcification via mediating valve interstitial cell osteogenic differentiation and endothelial dysfunction[J]. FASEB J, 2025, 39(6): e70437.
[33] Wang R, Bai Z, Zhang D, et al. Mediating effects of insulin resistance on the development of hypertension associated with elevated serum uric acid: A prospective cohort study[J]. J Hum Hypertens, 2022, 36(8): 760-766.
[34] Goli P, Riahi R, Daniali SS, et al. Association of serum uric acid concentration with components of pediatric metabolic syndrome: A systematic review and meta-analysis[J]. J Res Med Sci, 2020, 25: 43.
[35] Rutters F, den Braver NR, Lakerveld J, et al. Lifestyle interventions for cardiometabolic health[J]. Nat Med, 2024, 30(12): 3455-3467.
[36] Lambert JO, Beck A, Showell NN. Lifestyle interventions in pediatric primary care[J]. Pediatr Clin North Am, 2024, 71(5): 943-955.
[37] Li C, Lu J, Lyu Z, et al. Clinical practice consensus statement 2025: Management of hyperuricemia and gout in adolescents[J]. Int J Rheum Dis, 2025, 28(7): e70378.
[38] Tagi VM, Samvelyan S, Chiarelli F. Metabolic syndrome in children[J]. Minerva Pediatr, 2020, 72(4): 312-325.
[39] Barenbaum SR, Kumar RB, Aronne LJ. Management of medication-induced weight gain[J]. Gastroenterol Clin North Am, 2023, 52(4): 751-760.
[40] Ebstein E, Ottaviani S. Managing gout in patients with metabolic syndrome[J]. Drugs Aging, 2024,41(8):653-663.
[41] Wu J, Aga L, Tang L, et al. Lacticaseibacillus paracasei JS-3 Isolated from "Jiangshui" ameliorates hyperuricemia by regulating gut microbiota and iTS metabolism[J]. Foods, 2024,13(9):1371.